NuVasive (NUVA) Tops Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS/Revenue Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to NuVasive (NUVA) Tops Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS/Revenue Guidance Below Consensus

NuVasive (NUVA) PT Lowered to $70 at Canaccord Genuity

October 25, 2017 8:48 AM EDT

Canaccord Genuity lowered its price target on NuVasive (NASDAQ: NUVA) to $70.00 (from $75.00) while maintaining a Buy rating.

Analyst Kyle Rose said while concerns about the underlying health of the US spine market are likely to keep more cautious investors on the... More